Beijing Ql Biopharmaceutical Co.,ltd

This early-stage study tests whether ZT003 is safe and how it moves through the body in healthy adults and those who are overweight. About 76 participants will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels, not to treat any di…

This early-phase study looks at how a single dose of ZT002 (a potential weight-loss drug) behaves in people with different levels of kidney function. About 40 adults who are overweight or obese will receive one injection, and researchers will measure drug levels and safety. The g…